Design, Synthesis, and Mechanistic Evaluation of U12 Derivatives as Potent Anti-Hepatoma Agents Targeting G0/G1 Cell Cycle Arrest and Apoptosis via PI3K/AKT/mTOR Pathway
Pharmaceutical Sciences and Drug Design · 2025
DOI: 10.51847/1fsubm6pym ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2025. Verfasst von Nadine Laurent und 3 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Ursodeoxycholic acid (UDCA) is a well-established treatment for liver conditions, with its derivative, U12, showing notable anti-hepatoma effects in prior research. However, U12’s low polarity and the requirement for high dosages pose challenges to its druglikeness. In this study, twelve new derivatives of U12 were synthesized using substitution, esterification, and amidation methods, aimed at improving its pharmacological properties. Testing of these derivatives on hepatoma cell lines (HepG2) r
Zitieren
APA
Laurent, N., Lefevre, M., Dubois, S., & Robert, A. (2025). Design, Synthesis, and Mechanistic Evaluation of U12 Derivatives as Potent Anti-Hepatoma Agents Targeting G0/G1 Cell Cycle Arrest and Apoptosis via PI3K/AKT/mTOR Pathway. Pharmaceutical Sciences and Drug Design. https://doi.org/10.51847/1fsubm6pym
Vancouver
Laurent N, Lefevre M, Dubois S, Robert A. Design, Synthesis, and Mechanistic Evaluation of U12 Derivatives as Potent Anti-Hepatoma Agents Targeting G0/G1 Cell Cycle Arrest and Apoptosis via PI3K/AKT/mTOR Pathway. Pharmaceutical Sciences and Drug Design. 2025. doi:10.51847/1fsubm6pym
BibTeX
@article{Laurent2025,
author = {Laurent, Nadine and Lefevre, Marc and Dubois, Sophie and Robert, Alain},
title = {Design, Synthesis, and Mechanistic Evaluation of U12 Derivatives as Potent Anti-Hepatoma Agents Targeting G0/G1 Cell Cycle Arrest and Apoptosis via PI3K/AKT/mTOR Pathway},
journal = {Pharmaceutical Sciences and Drug Design},
year = {2025},
doi = {10.51847/1fsubm6pym}
}
EUVIMED